Skip to main content
Industry News
Hahn resigns as FDA commissioner
1/21/2021

Dr. Stephen Hahn, a radiation oncologist, has stepped down from his position as FDA commissioner and will be replaced in the interim by Dr. Janet Woodcock, director of the agency's Center for Drug Evaluation and Research. Hahn was part of the American Society for Radiation Oncology's board of directors before former President Donald Trump nominated him for the position in November 2019, a move celebrated by the radiation oncology community.

Full Story: